-
EP3707156
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3707156
| EP3707156 - GLP-1 RECEPTOR LIGAND MOIETY CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 14.08.2020 Database last updated on 02.08.2024 | |
| Former | The international publication has been made Status updated on 18.05.2019 | Most recent event Tooltip | 01.12.2023 | New entry: Renewal fee paid | Applicant(s) | For all designated states Ionis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad, CA 92010 / US | For all designated states Astrazeneca AB 151 85 Södertälje / SE | [2020/38] | Inventor(s) | 01 /
MONIA, Brett P. 2855 Gazelle Court Carlsbad California 92010 / US | 02 /
PRAKASH, Thazha P. 2855 Gazelle Court Carlsbad California 92010 / US | 03 /
KINBERGER, Garth A. 2855 Gazelle Court Carlsbad California 92010 / US | 04 /
LEE, Richard 2855 Gazelle Court Carlsbad California 92010 / US | 05 /
SETH, Punit P. 2855 Gazelle Court Carlsbad California 92010 / US | 06 /
OESTERGAARD, Michael 2855 Gazelle Court Carlsbad California 92010 / US | 07 /
NIKAN, Mehran 2855 Gazelle Court Carlsbad California 92010 / US | 08 /
ANDERSSON, Shalini c/o AstraZeneca AB 151 85 Södertälje / SE | 09 /
ÄMMÄLÄ, Eva Carina c/o AstraZeneca AB 151 85 Södertälje / SE | 10 /
KNERR, Daniel Laurent c/o AstraZeneca AB 151 85 Södertälje / SE | 11 /
ÖLWEGÅRD-HALVARSSON, Maria c/o AstraZeneca AB 151 85 Södertälje / SE | 12 /
DRURY, III, William John c/o AstraZeneca AB 151 85 Södertälje / SE | 13 /
VALEUR, Eric c/o AstraZeneca AB 151 85 Södertälje / SE | [2020/38] | Representative(s) | AstraZeneca Intellectual Property Eastbrook House Shaftesbury Road Cambridge CB2 8BF / GB | [N/P] |
| Former [2020/38] | AstraZeneca Milstein Building Granta Park Cambridge CB21 6GH / GB | Application number, filing date | 18875303.2 | 07.11.2018 | [2020/38] | WO2018IB58752 | Priority number, date | US201762583398P | 08.11.2017 Original published format: US 201762583398 P | US201862725176P | 30.08.2018 Original published format: US 201862725176 P | [2020/38] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2019092618 | Date: | 16.05.2019 | Language: | EN | [2019/20] | Type: | A2 Application without search report | No.: | EP3707156 | Date: | 16.09.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.05.2019 takes the place of the publication of the European patent application. | [2020/38] | Search report(s) | International search report - published on: | US | 18.07.2019 | (Supplementary) European search report - dispatched on: | EP | 06.07.2021 | Classification | IPC: | A61K47/64, C12N15/113, C07K14/535, C12N15/10, C12N15/64, A61P1/18 | [2021/31] | CPC: |
A61K47/64 (EP,IL,KR,US);
A61K47/6425 (US);
A61K31/7088 (KR);
A61K47/549 (US);
A61P1/18 (EP);
C12N15/113 (EP,IL,KR,US);
C12N15/1136 (US);
C12N2310/113 (EP,IL,KR,US);
C12N2310/315 (EP,IL,KR,US);
C12N2310/321 (US);
C12N2310/322 (EP,IL,KR);
C12N2310/3231 (EP,IL,KR);
C12N2310/3341 (EP,IL,KR);
C12N2310/341 (EP,IL,KR);
C12N2310/345 (EP,IL,KR);
C12N2310/346 (EP,IL,KR);
C12N2310/3513 (EP,IL,KR,US);
C12N2310/3525 (IL,KR);
C12N2320/35 (US)
(-)
| C-Set: |
C12N2310/322, C12N2310/3525 (EP)
|
| Former IPC [2020/38] | C07K14/535, C12N15/10, C12N15/64 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/38] | Title | German: | GLP-1-REZEPTOR-LIGANDENTEILKONJUGIERTE OLIGONUKLEOTIDE UND VERWENDUNGEN DAVON | [2020/38] | English: | GLP-1 RECEPTOR LIGAND MOIETY CONJUGATED OLIGONUCLEOTIDES AND USES THEREOF | [2020/38] | French: | OLIGONUCLÉOTIDES CONJUGUÉS À UNE FRACTION LIGAND DU RÉCEPTEUR DE GLP-1 ET LEURS UTILISATIONS | [2020/38] | Entry into regional phase | 08.06.2020 | National basic fee paid | 08.06.2020 | Search fee paid | 08.06.2020 | Designation fee(s) paid | 08.06.2020 | Examination fee paid | Examination procedure | 08.06.2020 | Examination requested [2020/38] | 01.02.2022 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 30.11.2020 | Renewal fee patent year 03 | 30.11.2021 | Renewal fee patent year 04 | 30.11.2022 | Renewal fee patent year 05 | 30.11.2023 | Renewal fee patent year 06 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XP]WO2017192820 (IONIS PHARMACEUTICALS INC [US], et al); | International search | [Y]US2017189441 (COLLETTI STEVEN L [US], et al); | [XY]US2017204422 (NELSON JENNIFER [US], et al); | [A]US2017202979 (CHAKRABORTY TIRTHA [US], et al) |